Liraglutide(4Moving Biotech)

N/A

Report date: 2025/11/11 20:00:28

Base Information

Drug NameLiraglutide(4Moving Biotech)
Drug Alias NameIntra-Articular Formulated Liraglutide(4Moving Biotech)4P-004
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsSynovitisOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInsermSorbonne University4P-Pharma Ltd
China Registration ClassN/A

Develop Information

Active Companies4Moving Biotech SAS4P-Pharma LtdSorbonne University
Inactive CompaniesN/A
Active IndicationsSynovitisOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A